연구동향 분석

Original Articlet：Diabetic Retinopathy Risk Factors: Plasma Erythropoietin as a Risk Factor for Proliferative Diabetic Retinopathy

( Yaghoobi Gholamhossein ) ( Heydari Behrouz ) ( Zarban Asghar ) 2014년

논문상세정보
인용/피인용
' Original Articlet：Diabetic Retinopathy Risk Factors: Plasma Erythropoietin as a Risk Factor for Proliferative Diabetic Retinopathy' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • diabetic retinopathy
  • risk factors
  • type 2 diabetes mellitus
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
418 0

0.0%

' Original Articlet：Diabetic Retinopathy Risk Factors: Plasma Erythropoietin as a Risk Factor for Proliferative Diabetic Retinopathy' 의 참고문헌

  • Serum inflammatory markers in diabetic retinopathy
    Meleth AD Invest Ophthalmol Vis Sci 46 : 4295 ~ 4301 [2005]
  • Risk factors for diabetic retinopathy in diabetics screened using fundus photography at a primary health care setting in East Malaysia
    Mallika PS Malays Fam Physician 6 : 60 ~ 65 [2011]
  • Risk factors associated with diabetic retinopathy in patients with diabetes mellitus type 2
    Chatziralli IP BMC Res Notes 3 : 153 ~ [2010]
  • Risk factors and diabetic retinopathy
    Dizdarevic A Med Glas 9 : 104 ~ 106 [2012]
  • Relationships of plasma interleukin-18 concentrations to hyperhomocysteinemia and carotid intimal-media wall thickness in patients with type 2 diabetes
    Aso Y Diabetes Care 26 : 2622 ~ 2627 [2003]
  • Prospective study of inflammatory biomarkers and risk of diabetic retinopathy in the diabetes control and complications trial
    Muni RH JAMA Ophthalmol 131 : 514 ~ 521 [2013]
  • Prevalence and risk factors for diabetic retinopathy: the Korea National Health and Nutrition Examination Survey 2008-2011
    Jee D Invest Ophthalmol Vis Sci 54 : 6827 ~ 6833 [2013]
  • Prevalence and risk factors for diabetic retinopathy: an Iranian eye study
    Heydari B Eur J Ophthalmol 22 : 393 ~ 397 [2012]
  • PEDF in diabetic retinopathy: a protective effect of oxidative stress
    Zhu XF J Biomed Biotechnol 2012 : 580687 ~ [2012]
  • Novel role of erythropoietin in proliferative diabetic retinopathy
    Takagi H Diabetes Res Clin Pract 77 : S62 ~ S64 [2007]
  • Monocyte chemotactic protein-1, nitrite and C-reactive protein in diabetic retinopath
    Hadhoud KM J Am Sci 8 : 109 ~ 118 [2012]
  • Microvascular complications and risk factors in patients with type 2 diabetes
    Del Canizo Gomez FJ Endocrinol Nutr 58 : 163 ~ 168 [2011]
  • Markers of insulin resistance are strong risk factors for retinopathy incidence in type 1 diabetes
    Chaturvedi N Diabetes Care 24 : 284 ~ 289 [2001]
  • Intravitreal injection of erythropoietin protects against retinal vascular regression at the early stage of diabetic retinopathy in streptozotocin-induced diabetic rats
    Mitsuhashi J Exp Eye Res 106 : 64 ~ 73 [2013]
  • Inflammatory markers and diabetic retinopathy in type 1 diabetes
    Izuora KE Diabetes Care 28 : 714 ~ 715 [2005]
  • Imbalanced levels of angiogenic and angiostatic factors in vitreous, plasma and postmortem retinal tissue of patients with proliferative diabetic retinopathy
    Mohan N J Diabetes Complications 26 : 435 ~ 441 [2012]
  • Erythropoietin therapy for early diabetic retinopathy through its protective effects on retinal pericytes
    Wang ZY Med Hypotheses 76 : 266 ~ 268 [2011]
  • Erythropoietin levels in aqueous humour in eyes with exudative age-related macular degeneration and diabetic retinopathy
    Jonas JB Clin Experiment Ophthalmol 35 : 186 ~ 187 [2007]
  • Erythropoietin as a retinal angiogenic factor in proliferative diabetic retinopathy
    Watanabe D N Engl J Med 353 : 782 ~ 792 [2005]
  • Diabetic retinopathy in diabetics referred to a tertiary centre from a nationwide screening programme
    Lim MC Ann Acad Med Singapore 37 : 753 ~ 759 [2008]
  • Diabetic retinopathy
    Antonetti DA N Engl J Med 366 : 1227 ~ 1239 [2012]
  • Diabetic macular oedema and erythropoietin
    Uparkar M Eye 23 : 1747 ~ 1748 [2009]
  • Diabetes mellitus
    Riaz S Sci Res Essay 4 : 367 ~ 373 [2009]
  • Detection of circulating microparticles in patients with proliferative diabetic retinopathy
    Khodeir SA Life Sci J 9 : 204 ~ 209 [2012]
  • C-reactive protein, body mass index, and diabetic retinopathy
    Lim LS Invest Ophthalmol Vis Sci 51 : 4458 ~ 4463 [2010]
  • Apolipoproteins and diabetic retinopathy
    Chait A Diabetes Care 34 : 529 ~ 531 [2011]
  • A shift in the balance of vascular endothelial growth factor and connective tissue growth factor by bevacizumab causes the angiofibrotic switch in proliferative diabetic retinopathy
    Van Geest RJ Br J Ophthalmol 96 : 587 ~ 590 [2012]
  • A hypothesis: can erythropoietin administration affect the severity of retinopathy in diabetic patients with renal failure?
    Diskin CJ Am J Med Sci 334 : 260 ~ 264 [2007]